Regenerative Medicine and Tissue Engineering: Transforming Healthcare

Vivek Pazhamalai Vels Institute of Science, Technology and Advanced Studies, Chennai, India https://orcid.org/0000-0003-2088-7545 P. Dharshika Vels Institute of Science, Technology and Advanced Studies, Chennai, India https://orcid.org/0009-0009-7342-297X Kosireddy Vanitha Vels Institute of Science, Technology and Advanced Studies, Chennai, India https://orcid.org/0009-0008-7348-1235 V. T. Thanush Vels Institute of Science, Technology and Advanced Studies, Chennai, India https://orcid.org/0009-0009-6895-3442 S. Ivo Romauld Vels Institute of Science, Technology and Advanced Studies, Chennai, India https://orcid.org/0000-0003-0610-0646 S. S. Meenambiga Vels Institute of Science, Technology and Advanced Studies, Chennai, India https://orcid.org/0000-0002-5445-525X K. Rajakumari Vels Institute of Science, Technology and Advanced Studies, Chennai, India https://orcid.org/0000-0002-8102-9512 Regenerative Medicine and Tissue Engineering Transforming Healthcare

Tissue engineering, stem cells, and cloning are just a few of the technological fields that falls under regenerative medicine. Tissue engineering techniques utilize the cellular matrices, which rely on the body's inherent capacity for regeneration to ensure that new tissue growth is properly oriented and directed, and the use of matrices containing cells. Biomaterials give cells a three-dimensional environment in which to develop into new tissues with the right structure and function. They can also facilitate the distribution of cells and the right bioactive substances, such as growth factors and cell adhesion peptides, to the body's intended locations. Current regulations and ethical considerations advise that before a novel tissue engineering and regenerative medicine technique or instrument is implemented into standard clinical practice and used by numerous patients, controlled randomized clinical trials must be carried out. Clinical studies involving regeneration treatments have revealed some restrictions, difficulties, and unknowns.
chapter 9 2025 4 25 311 334 10.4018/979-8-3373-1305-4.ch009 20250613013425 https://services.igi-global.com/resolvedoi/resolve.aspx?doi=10.4018/979-8-3373-1305-4.ch009 https://www.igi-global.com/viewtitle.aspx?TitleId=377590 10.1089/154916804323105053 10.1097/01.mop.0000193294.94646.be 10.1146/annurev-chembioeng-061010-114257 10.3389/fbioe.2022.1125027 10.3390/pr11092696 10.1016/j.progpolymsci.2012.05.003 10.3390/antiox9040315 10.1126/science.1116447 10.1016/B978-0-08-100979-6.00009-4 10.1039/C7PY00826K 10.1208/s12249-022-02419-1 10.2217/rme-2021-0016 10.1016/j.stemcr.2015.09.011 10.3389/fsurg.2018.00070 10.1016/B978-0-12-398358-9.00006-9 10.1089/ten.teb.2017.0081 10.14748/bmr.v23.26 10.1002/adma.200802977 10.1007/s00167-008-0663-2 10.1053/j.sempedsurg.2014.06.010 10.3390/biomedicines10061439 10.1038/nature13426 10.1089/107632704322791943 10.1155/2016/6940283 10.1016/B978-0-12-812034-7.00008-X 10.3390/bioengineering11020198 10.2217/17460751.3.1.1 10.1016/j.actbio.2015.11.007 10.4068/cmj.2011.47.1.1 10.4068/cmj.2011.47.1.1 10.3390/ma12111824 10.1038/nature11317 10.1038/srep16595 10.3233/BME-2012-0684 10.1126/science.282.5391.1145 10.1016/j.ydbio.2015.12.003